| Migraine |
1 |
1 |
| Pain |
0 |
0.68 |
| Pain Management |
0 |
0.47 |
| Brain |
0 |
0.37 |
| Nerve |
0 |
0.37 |
| Dorsum |
0 |
0.31 |
| Food and Drug Administration (FDA) |
0 |
0.18 |
| Aura |
0 |
0.12 |
| Child |
0 |
0.12 |
| Headache |
0 |
0.12 |
| Neurotransmitters |
0 |
0.12 |
| New York |
0 |
0.12 |
| Stress |
0 |
0.12 |
| Epilepsy |
0 |
0.09 |
| Toxicology |
0 |
0.09 |
| Adolescent Medicine |
0 |
0.06 |
| Anticonvulsant |
0 |
0.06 |
| Antidepressant drug |
0 |
0.06 |
| Anxiety |
0 |
0.06 |
| Botox |
0 |
0.06 |
| Caregiver |
0 |
0.06 |
| Cervical Region |
0 |
0.06 |
| Face |
0 |
0.06 |
| Frontal Region |
0 |
0.06 |
| Injectable Medications |
0 |
0.06 |
| Insurance |
0 |
0.06 |
| Meditation |
0 |
0.06 |
| Muscle |
0 |
0.06 |
| Nonpharmacologic |
0 |
0.06 |
| Pandemic |
0 |
0.06 |
| Tryptamine |
0 |
0.06 |
| Weakness |
0 |
0.06 |
| Anxiety Disorder |
0 |
0.04 |
| Complementary and Alternative Medicine |
0 |
0.04 |
| Depression |
0 |
0.04 |
| Pregnancy |
0 |
0.04 |
| Revenue and Practice Management |
0 |
0.04 |